Free Trial

Wellington Management Group LLP Purchases 1,878,145 Shares of Perrigo Company plc (NYSE:PRGO)

Perrigo logo with Medical background

Wellington Management Group LLP grew its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 229.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,697,698 shares of the company's stock after acquiring an additional 1,878,145 shares during the quarter. Wellington Management Group LLP owned about 1.98% of Perrigo worth $70,761,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. CWM LLC increased its stake in Perrigo by 877.0% during the 2nd quarter. CWM LLC now owns 8,197 shares of the company's stock valued at $210,000 after purchasing an additional 7,358 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Perrigo by 31.9% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 14,968 shares of the company's stock worth $384,000 after acquiring an additional 3,619 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of Perrigo in the 2nd quarter worth about $840,000. Raymond James & Associates lifted its position in Perrigo by 5.9% in the 2nd quarter. Raymond James & Associates now owns 86,380 shares of the company's stock valued at $2,218,000 after acquiring an additional 4,849 shares in the last quarter. Finally, Lecap Asset Management Ltd. acquired a new position in Perrigo during the 2nd quarter valued at about $304,000. 95.91% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Katherine C. Doyle sold 8,954 shares of Perrigo stock in a transaction on Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the completion of the transaction, the director now directly owns 6,009 shares in the company, valued at approximately $164,045.70. The trade was a 59.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the sale, the director now directly owns 5,409 shares in the company, valued at $152,912.43. This trade represents a 76.49 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.70% of the company's stock.

Perrigo Stock Performance

Shares of NYSE PRGO traded down $0.29 during midday trading on Wednesday, reaching $27.30. The company's stock had a trading volume of 876,352 shares, compared to its average volume of 1,605,472. The stock has a market capitalization of $3.72 billion, a P/E ratio of -23.58 and a beta of 0.52. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The firm has a 50 day moving average price of $26.37 and a 200-day moving average price of $26.97. Perrigo Company plc has a 12-month low of $23.89 and a 12-month high of $34.60.

Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.81 earnings per share for the quarter, hitting the consensus estimate of $0.81. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.09 billion for the quarter, compared to analysts' expectations of $1.12 billion. During the same quarter in the previous year, the firm earned $0.64 earnings per share. The business's revenue was down 3.2% on a year-over-year basis. As a group, equities analysts predict that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Friday, November 29th will be issued a dividend of $0.276 per share. The ex-dividend date is Friday, November 29th. This represents a $1.10 dividend on an annualized basis and a yield of 4.04%. Perrigo's dividend payout ratio (DPR) is presently -94.02%.

Analyst Ratings Changes

Several analysts have recently commented on the company. Canaccord Genuity Group reissued a "buy" rating and issued a $42.00 price objective on shares of Perrigo in a research note on Monday, September 30th. StockNews.com raised Perrigo from a "hold" rating to a "buy" rating in a research report on Thursday, November 7th. Finally, Jefferies Financial Group reaffirmed a "hold" rating and set a $30.00 price objective (down from $50.00) on shares of Perrigo in a report on Monday, September 23rd. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Perrigo currently has a consensus rating of "Moderate Buy" and an average target price of $37.00.

Check Out Our Latest Research Report on PRGO

Perrigo Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Further Reading

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

→ Genesis leading the smart algo revolution? (From Diversified Trading Institute) (Ad)

Should you invest $1,000 in Perrigo right now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner

Amazon is set to continue its dominance in 2025, fueled by its robust e-commerce platform and the unmatched power of AWS in the data center space.

Related Videos

Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines